CTRI/2018/07/015116Other未知
A blood test to determine the probability of developing cancer and/ or its stage, by analysing theexpression profile of molecular immuno-markers in healthy and cancer patients. - BTFDC
试验速览
- 阶段
- 未知
- 状态
- Other
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Cancer group - Have a type of cancer disease.
- •2. Healthy group - who are not on any regular medication.
- •3. Are aged 21 years or older.
- •4. Are willing to consent to the storage of specimens for
- •future research.
- •5. Subjects enrolled will be able to provide informed
- •consent for themselves.
排除标准
- •1. Are incarcerated.
- •2 Are unwilling or unable to comply with prescribed
- •3. Subjects that lack the capacity to provide informed
- •consent autonomously are to be excluded.
- •4. Pregnant or lactating women.
- •5. Subjects who have participated in any clinical trial
- •in the past 1 month.
- •6. Any other condition that in the opinion of the
- •investigator that does not justify the subjectâ??s
- •participation in the trial.
研究者
相似试验
已完成
不适用
blood test to detect the presence or absence of cancerCTRI/2019/01/017166Epigeneres Biotech Pvt Ltd1,000
招募中
不适用
Valuable screening test to determine the cause of uveitis using sample like aqueous humoruveitisJPRN-UMIN000032480Asai hospital200
招募中
不适用
Collection of blood samples for the evaluation of the analytical performance of two new in vitro test systems for tuberculosis diagnosticsA15-A19TuberculosisDRKS00027129R-Biopharm AG636
招募中
不适用
A minimally invasive and simple screening test for detection of pancreatic cancer using biomarkers in duodenal juicePancreatic diseasesJPRN-UMIN000020214Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University350
已完成
不适用
To test the number of Circulating Tumor Cells (CTC) captured by the OncoDiscover Liquid Biopsy in peripheral blood samples of Head and Neck cancer patients.CTRI/2018/03/012905Actorius Innovations and Research Pvt Ltd100